ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2018 American Transplant Congress

    The Effects of Age-Adjusted Marriage Duration on Graft Outcomes in Spousal Donor Kidney Transplantation

    M. Yu,1 J. Park,2 H. Cho,1 J. Ha,1 C. Ahn,1 Y. Kim,1 H. Lee.1

    1Seoul National University Hospital, Seoul, Korea; 2Kangwon National University Hospital, Chuncheon, Korea.

    It is well known that graft survival rate in spousal donor kidney transplantation (SKT) is similar to that of living related donor kidney transplantation (LRKT)…
  • 2018 American Transplant Congress

    Long-Term Outcomes of Graft Function in Elderly Kidney Transplant Recipients

    I. Bajjoka, A. Yaldo, C. Crombez, M. Abouljoud.

    Henry Ford Transplant Institute, Detroit, MI.

    Purpose: To compare and evaluate 5-year outcomes of graft function for younger (Y) versus elderly (E) kidney transplant recipients (KTR).Introduction: As the number of elderly…
  • 2018 American Transplant Congress

    Predicting Acute Kidney Injury after Orthotopic Liver Transplantation Using a Recurrent Neural Network

    A. Bishara, R. Kothari, M. Bokoch, C. Niemann, D. Adelmann.

    UCSF, San Francisco.

    In patients undergoing orthotopic liver transplantation (OLT), the incidence of acute kidney injury (AKI) is up to 60%. Prediction of the individual patient's risk of…
  • 2018 American Transplant Congress

    Postoperative Immunological Profiles of Adult ABO-Incompatible Living Donor Liver Transplant Recipients

    T-.J. Wu, Y-.C. Wang, C-.H. Cheng, T-.H. Wu, C-.F. Lee, H. Chou, K-.M. Chan, W-.C. Lee.

    Division of Liver and Transplantation Surgery, Department of General Surgery, Chang-Gung Memorial Hospital, Chang-Gung University College of Medicine, Taoyuan, Taiwan.

    Background: Adult ABO-incompatible (ABOi) living donor liver transplantation has been performed for acute liver failure or end stage liver diseases when deceased liver allografts or…
  • 2018 American Transplant Congress

    Impact of Preserved Collateral Veins on Small-for-Size Grafts in Living Donor Liver Transplantation

    B-.G. Na, E. Lee, S. Kim, S. Park.

    Center for Liver Cancer, National Cancer Center Research Institute, Goyang, Republic of Korea.

    Purpose: Graft size is a critical issue in living donor liver transplantation (LDLT). We hypothesized that too much portal flow could possibly be diverted into…
  • 2018 American Transplant Congress

    Liver Transplantation Post Gastric Bypass: Surgical Complications and Outcomes

    A. Vijay, A. Nigam, R. Girlanda, A. Kroemer, J. Hawksworth, C. Matsumoto, T. Fishbein.

    Transplant Surgery, Medstar Georgetown Transplant Institute, Washington, DC.

    Introduction: Liver transplantation in patients with prior gastric bypass poses a unique challenge and may increase the risk of complications.Aim: To characterize surgical complications in…
  • 2018 American Transplant Congress

    Identifying Patients with CPRA>99.95% Likely to Be Offered Deceased Donor Kidneys

    R. Parsons, S. Bumb, H. Decker, R. Bray, H. Gebel.

    Emory Transplant Center, Atlanta, GA.

    The implementation of the new kidney allocation system and priority of kidneys for cPRA=100% subjects revealed a hierarchy difference in allocation to patients with cPRA=99.45%-100%.…
  • 2018 American Transplant Congress

    GDF15 Preventing Renal Ischemia Reperfusion Injury

    C. Zhu,1,2 A. Patel,1 Y. Su,1,2 J. Jiang,1 D. Lian,1 A. Sener,1 W. Min,1 P. Luke,1 D. Quan,1 K. Liu,2 X. Zheng.1

    1University of Western Ontario, London, ON, Canada; 2Jilin University, ChangChun, China.

    Rationale: Ischemia reperfusion (I/R) injury still remains one of main causes of early renal dysfunction in kidney transplantation. There are no effective treatments for preventing…
  • 2018 American Transplant Congress

    mTORC2 Deficiency in CD11c+ dendritic Cells Promotes Acute Kidney Injury

    H. Dai,1,2 A. Watson,1 D. Fantus,1 L. Peng,2 A. Thomson,1 N. Rogers.1

    1Starzl Transplantation Institute, University of Pittsburgh School of Medicine, Pittsburgh; 2Department of Urological Organ Transplantation, The Second Xiangya Hospital of Central South University, Changsha, China.

    Introduction: The role of the mammalian/mechanistic target of rapamycin (mTOR) in the pathophysiology of renal ischemia-reperfusion injury (IRI) is poorly characterized; furthermore, the influence of…
  • 2018 American Transplant Congress

    Five-Year Outcomes after Randomized Treatment by Rituximab in Early Acute Antibody-Mediated Rejection in Renal Transplantation: Long Term Outcomes of the RITUX ERAH Study

    E. Bailly,1 G. Blancho,2 S. Ville,2 E. Morelon,3 J. Bamoulid,4 S. Caillard,5 V. Chatelet,6 P. Malvezzi,7 J. Tourret,8 V. Vuiblet,9 D. Anglicheau,10 D. Bertrand,11 P. Grimbert,12 F. Haidar,13 M. Hazzan,14 N. Kamar,15 P. Merville,16 C. Mousson,17 V. Pernin,18 C. Pouteil-Noble,19 R. Purgus,20 J. Sayegh,21 P. Westeel,22 M. Büchler.1

    1University Hospital, Tours, France; 2Institut de Transplantation-Urologie-Néphrologie, Nantes, France; 3University Hospital, Lyon Edouard Herriot, France; 4University Hospital, Besançon, France; 5University Hospital, Strasbourg, France; 6University Hospital, Caen, France; 7University Hospital, Grenoble, France; 8Pitié Salpêtrière Hospital, APHP, Paris, France; 9University Hospital, Reims, France; 10Necker Hospital, APHP, Paris, France; 11University Hospital, Rouen, France; 12Mondor Hospital, APHP, Paris, France; 13Territorial Hospital, Noumea, France; 14University Hospital, Lille, France; 15University Hospital, Toulouse, France; 16University Hospital, Bordeaux, France; 17University Hospital, Dijon, France; 18University Hospital, Montpellier, France; 19University Hospital, Lyon Sud, France; 20University Hospital, Marseille, France; 21University Hospital, Angers, France; 22University Hospital, Amiens, France.

    Background The place of rituximab in the treatment of acute antibody-mediated rejection (ABMR) is still controversial. The French multicenter double-blind, placebo-controlled RITUX ERAH study included…
  • 1
  • 2
  • 3
  • …
  • 211
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2026 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences